New hope for kids with tough cancer: trial tests supercharged treatment
NCT ID NCT03786783
Summary
This study is testing whether adding an immunotherapy drug called dinutuximab to standard chemotherapy works better for children newly diagnosed with high-risk neuroblastoma, a serious childhood cancer. The trial involves 42 young patients and aims to see if this combination is safe and can better control the disease. The treatment plan is intensive, involving multiple rounds of chemotherapy, stem cell transplants, and radiation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH RISK NEUROBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
-
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania, 15224, United States
-
Children's National Medical Center
Washington D.C., District of Columbia, 20010, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
New York, New York, 10032, United States
-
Primary Children's Hospital
Salt Lake City, Utah, 84113, United States
-
Royal Children's Hospital
Parkville, Victoria, 3052, Australia
-
Saint Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
-
Starship Children's Hospital
Grafton, Auckland, 1145, New Zealand
-
The Children's Hospital at Westmead
Westmead, New South Wales, 2145, Australia
Conditions
Explore the condition pages connected to this study.